MedCity News
MARCH 28, 2024
One year after the Medicaid continuous enrollment provision ended, 19.2 million people have been disenrolled from Medicaid, according to KFF. This is higher than many expected, and experts have mixed reviews on how they think this process has gone.
Fierce Pharma
MARCH 28, 2024
An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. | An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. suggests intelligence officials and lawmakers may have good reason to be concerned about the CDMO’s potential political ties to its home country.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 28, 2024
The lack of adoption of interoperability tools by healthcare providers is a complex issue that requires a multi-faceted approach
Fierce Pharma
MARCH 28, 2024
Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits that claim the company’s iconic baby powder can cause ovarian cancer. | Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits claiming that the company’s iconic baby powder can cause ovarian cancer. A New Jersey court ruled on Wednesday that J&J can contest the scientific findings that back those cases.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
MARCH 28, 2024
Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its pipeline, including a lead program on track to report preliminary data later this year.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 28, 2024
This technology can result in reduced readmission rates, increased patient satisfaction, and a consistent flow of post-acute care revenue, especially in rural areas.
Fierce Pharma
MARCH 28, 2024
After news broke earlier this month that Danish antibody specialist Genmab would receive up to $8.4 million in state tax credits as part of a plan to grow its presence in Plainsboro, New Jersey, re | Genmab has snared a lease to upsize its U.S. presence and create 300 new jobs as part of its Epkinly marketing push in diffuse large B-cell lymphoma.
MedCity News
MARCH 28, 2024
Here is a list of some of the most notable funding round announcements that took place this March in the provider technology space.
Fierce Pharma
MARCH 28, 2024
[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaVoice
MARCH 28, 2024
With Zola Therapeutics, Krieg plans to design and sell a series of cancer immunotherapies without the help of outside investors, he told BioPharma Dive.
Fierce Pharma
MARCH 28, 2024
Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. and China. U.S. | Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. and China.
Evolve Your Success
MARCH 28, 2024
Embark on a journey into the heart-pounding, adrenaline-charged world of medical sales with your host, Samuel Adeyinka, and special guest, Chad Casey , VP of Sales at Zimmer Biomet. Chad is currently the Vice President of Sports Medicine, Extremities, Trauma, and ASC strategy for Zimmer Biomet Carolinas. He is a successful sales executive with over 23 years of experience.
PharmaVoice
MARCH 28, 2024
Novo Nordisk’s acquisition of Cardior Pharmaceuticals is a bet on new approaches to cardiovascular disease, says Cardior CEO Claudia Ulbrich.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaTimes
MARCH 28, 2024
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Pharmaceutical Technology
MARCH 28, 2024
According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58.
PharmaTimes
MARCH 28, 2024
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
pharmaphorum
MARCH 28, 2024
Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
PharmaTimes
MARCH 28, 2024
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
pharmaphorum
MARCH 28, 2024
Moderna’s development of mRNA vaccines for influenza will be backed by up to $750m in funding from Blackstone in a risk-sharing deal
Pharmaceutical Commerce
MARCH 28, 2024
The latest news for pharma industry insiders.
pharmaphorum
MARCH 28, 2024
New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
European Pharmaceutical Review
MARCH 28, 2024
A paper published in Applied Sciences has described a quality risk assessment methodology for application in sterile PET radiopharmaceutical production under Good Manufacturing Practice (GMP) regulations. According to research highlighted in the paper, applying quality standards such as GMP and ISO 9001 “guarantees the quality and safety of a radiopharmaceutical and contributes to optimising the performance and efficacy of the entire production process.
pharmaphorum
MARCH 28, 2024
Akebia’s Vafseo has been approved in the US as a treatment for anaemia caused by chronic kidney disease in dialysis patients, the first direct rival to GSK’s Jesduvroq.
Pharmaceutical Technology
MARCH 28, 2024
Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP).
pharmaphorum
MARCH 28, 2024
Study finds AI analysis of Google Street View images could reveal how built environment factors affect the risk of cardiovascular disease
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
European Pharmaceutical Review
MARCH 28, 2024
The global pharmaceutical and biotechnology environmental monitoring market valued $24 billion in 2023, according to a report by Verified Market Research. This figure is projected to increase to $38.1 billion by 2030. Pharmaceutical and biotechnology environmental monitoring market Influencing factors The report also covered that due to the biotechnology industry requiring sterile conditions and products, expansion of this sector creates demand for extensive environmental monitoring.
Pharmaceutical Technology
MARCH 28, 2024
Boundless has two assets in clinical trials targeting extrachromosomal DNA in cancer patients.
Pharmacy Times
MARCH 28, 2024
As the full act will be enforced in November 2024, all medication dispensers must ensure they’re fully prepared.
Expert insights. Personalized for you.
317 
Let's personalize your content